The reconstitution of this CCR6-negative microenvironment with MMTV-PyMT Ccr6WT TAMs restored the tumor-promoting properties of mammary stroma, indicating that breast cancer can be therapeutically targeted through manipulation of the CCR6-CCL20 axis to control tumor-infiltrating macrophages. This evidence concerns the gene CCR6 and breast carcinoma.